Article: “NRG Oncology Assessment of Artificial Intelligence Deep Learning-Based Auto-segmentation for Radiation Therapy: Current Developments, Clinical Considerations, and Future Directions”
Dr. Jeffrey C. Buchsbaum and colleagues assess in-house and commercially available AI models, evaluation metrics, clinical challenges, and limitations, as well as future developments for radiation therapy. [Int J Radiat Oncol Biol Phys. 2023 Nov 14:S0360-3016(23)08039-2. doi: 10.1016/j.ijrobp.2023.10.033. Online ahead of print.]
Yi Rong, PhD, Quan Chen, PhD, Yabo Fu, PhD, Xiaofeng Yang, PhD, Hania A. Al-Hallaq, PhD, Q. Jackie Wu, PhD, Lulin Yuan, PhD, Ying Xiao, PhD, Bin Cai, PhD, Kujtim Latifi, PhD, Stanley H. Benedict, PhD, Jeffrey C. Buchsbaum, MD, PhD, X. Sharon Qi, PhD
Read more:
-------------------------------------------------------------------------------------------------------------------
Article: “Technical note: A small animal irradiation platform for investigating the dependence of the FLASH effect on electron beam parameters”
Drs. Kevin E Byrne, Yannick Poirier, Isabel Lauren Jackson, Kai Jiang, and colleagues discuss how a high-throughput, variable dose rate platform that has been developed and commissioned for murine WTLI electron FLASH radiotherapy. [Med Phys. 2024 Jan 11. doi: 10.1002/mp.16909. Online ahead of print.]
Kevin E Byrne, Yannick Poirier, Junliang Xu, Andrew Gerry, Mark J Foley, Isabel Lauren Jackson, Amit Sawant, Kai Jiang
Read more:
Editorial: “Radiation Biodosimetry: Current Status and Future Initiatives”
Dr. Helen Turner and colleagues discuss new advances in the field of radiation biodosimetry and future research initiatives for developing novel biodosimetry assays. [Cytogenet Genome Res. 2023 Nov 29. doi: 10.1159/000535488.]
Adayabalam S Balajee, Helen C Turner, Ruth C Wilkins
Read more:
Article: “Radiation Biodosimetry: Current Status and Future Initiatives”
Article: “Development of Drug Products for the Treatment of Acute Radiation Syndrome”
Marzella Libero, MD, Director of the Division of Imaging and Radiation Medicine, summarizes the key elements of successful regulatory strategies for the development of drug products for acute radiation syndrome under the Animal Rule. [Disaster Med Public Health Prep. 2024 Jan 2:17:e571. doi: 10.1017/dmp.2023.227.]
Marzella Libero
Read more:
Article: “Development of Drug Products for the Treatment of Acute Radiation Syndrome”
